Access to anonymised data

We support clinical research and encourage the use of our data to expand the understanding of and ability to treat dermatological and other diseases.

LEO Pharma recognises that new scientific discoveries can be made from existing data sources, including the individual patient-level data from our clinical trials. We support clinical research and encourage the use of our data to expand the understanding of and ability to treat dermatological and other diseases.

We welcome external researchers to request access to anonymised patient-level data from clinical trials sponsored by LEO Pharma, investigating approved products in approved indications (trials from 2000* and onwards) or projects where the development has been discontinued (trials from 2014* and onwards). Requests can be made after the clinical trial report has been posted on the website.

For application forms and instructions on how to request access to data, please see the section 'For professionals'.

*Refers to the year of the clinical trial protocol.